We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDp Poland Regulatory News (DPP)

Share Price Information for Dp Poland (DPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.75
Bid: 10.50
Ask: 11.00
Change: 0.25 (2.38%)
Spread: 0.50 (4.762%)
Open: 10.50
High: 10.75
Low: 10.50
Prev. Close: 10.50
DPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: DP Poland (DPP.L): FY18 results announced

26 Mar 2019 16:42

Hardman & Co Research Hardman & Co Research: DP Poland (DPP.L): FY18 results announced 26-March-2019 / 16:42 GMT/BST


Hardman & Co Research: FY18 results announced

DPP announced FY18 results this morning, which, as previously trailed, were impacted by unseasonally warm weather and competitive marketing activity by delivery aggregators, but still managed 24% growth in system sales. The company raised £5.5m net in a placing in February, which should fund store growth through to 2020 and support its innovative online marketing programme. January and February comparisons were tough because of the TV advertising conducted in the same period last year. The growth focus will be on splitting territories and larger cities. DPP is also looking to sell some stores to sub-franchisees and maybe close some underperformers.

Please click here for the full report:

https://www.hardmanandco.com/research/corporate-research/fy18-results-announced/

To contact us: Hardman & Co 35 New Broad Street London EC2M 1NH www.hardmanandco.comFollow us on Twitter @HardmanandCo Contact: Jason Streets +44 20 7194 7622 js@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

791951 26-March-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
19th Apr 20241:21 pmRNSHolding(s) in Company
19th Apr 20249:57 amRNSDirector/PDMR Dealing
18th Apr 20241:40 pmRNSResult of General Meeting
16th Apr 20247:00 amRNSResult of Retail Offer
3rd Apr 20247:00 amRNSPublication of Circular
28th Mar 20244:01 pmRNSLaunch of Retail Offer
28th Mar 20244:00 pmRNSResult of Placing
28th Mar 202411:05 amRNSClose of Bookbuild
27th Mar 20244:45 pmRNSProposed Fundraise
16th Jan 20247:00 amRNSTrading Update
15th Nov 20237:00 amRNSBoard Changes
14th Nov 20237:00 amRNSTrading Update
10th Oct 20237:00 amRNSBoard Changes
26th Sep 20237:00 amRNSInterim Results & Trading Update
22nd Sep 20237:00 amRNSNotice of Interim Results
28th Jul 202312:21 pmRNSResult of AGM
28th Jul 20237:00 amRNSBoard Changes & Related Party Transaction
21st Jul 20237:00 amRNSTrading Update
4th Jul 20237:00 amRNSPosting of Annual Report & Notice of AGM
3rd Jul 20237:00 amRNSIssue of Options
30th Jun 20237:00 amRNSFinal Results
30th May 202312:02 pmRNSTrading Update
25th May 202311:55 amRNSExercise of Options & TVR
20th Apr 20237:00 amRNSTrading Update
10th Mar 202311:00 amRNSBoard Changes
20th Jan 20237:00 amRNSBoard Changes
17th Jan 20237:00 amRNSTrading Update
30th Dec 20227:00 amRNSBoard Changes
10th Nov 20224:09 pmRNSIssue of Options, Exercise of Options & TVR
9th Nov 20227:00 amRNSBoard Changes
28th Sep 20227:00 amRNSInterim Results and Trading Update
23rd Sep 202212:00 pmRNSNotice of Interim Results
12th Sep 20223:50 pmRNSHolding(s) in Company
30th Aug 20227:00 amRNSProposed Board Changes and Issue of Options
19th Aug 20226:02 pmRNSResult of Placing & Subscriptions
19th Aug 20225:05 pmRNSClose of Bookbuild
18th Aug 20224:37 pmRNSProposed Fundraise
10th Aug 202212:28 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSBoard Changes and Issue of Options
29th Jul 202212:13 pmRNSCompletion of Acquisition
15th Jul 202211:52 amRNSResult of AGM
15th Jul 20227:00 amRNSTrading Update
17th Jun 20227:00 amRNSPosting of Annual Report and Notice of AGM
16th Jun 20225:37 pmRNSHolding(s) in Company
16th Jun 202212:02 pmRNSDirector/PDMR Shareholding
15th Jun 20227:05 amRNSAcquisition, Board Changes & Issue of Options
15th Jun 20227:00 amRNSFinal Results and Trading Update
21st Apr 20227:00 amRNSTrading Update
5th Apr 20227:00 amRNSBoard Changes
4th Apr 20223:33 pmRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.